Estrace: Effective Estrogen Therapy for Menopause Symptom Relief
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.92 | $55.29 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $82.93 $75.39 (9%) | 🛒 Add to cart |
| 120 | $0.80 | $110.57 $95.50 (14%) | 🛒 Add to cart |
| 180 | $0.75 | $165.86 $135.70 (18%) | 🛒 Add to cart |
| 270 | $0.73 | $248.79 $196.02 (21%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $331.72 $256.33 (23%) | 🛒 Add to cart |
Estrace (estradiol) is a bioidentical hormone replacement therapy (HRT) formulated to replenish declining estrogen levels in menopausal and postmenopausal women. As a prescription medication containing 17β-estradiol—the primary estrogen produced by the ovaries—it closely mimics the body’s natural hormone, offering targeted relief from vasomotor symptoms, vulvovaginal atrophy, and osteoporosis prevention. Administered orally or topically, Estrace provides customizable dosing to align with individual patient needs and health profiles under medical supervision. Its well-established efficacy and safety profile make it a cornerstone in menopausal management, supporting both short-term symptom control and long-term health maintenance.
Features
- Contains 17β-estradiol, a bioidentical form of estrogen
- Available in multiple formulations: oral tablets (0.5 mg, 1 mg, 2 mg) and topical creams (0.01%)
- Precisely standardized dosing for consistent hormonal delivery
- FDA-approved for treatment of moderate to severe vasomotor symptoms and vulvovaginal atrophy
- Also indicated for prevention of postmenopausal osteoporosis
- May be used as part of combination hormone therapy with a progestin for women with an intact uterus
Benefits
- Significantly reduces frequency and severity of hot flashes and night sweats
- Restores vaginal tissue elasticity and moisture, relieving dyspareunia and urinary discomfort
- Helps prevent bone density loss and reduces fracture risk in postmenopausal women
- Improves overall quality of life by alleviating disruptive menopausal symptoms
- Offers flexible administration routes to accommodate patient preference and medical needs
- Supports cardiovascular and cognitive health when initiated early in menopause (within the “window of opportunity”)
Common use
Estrace is primarily prescribed for the management of menopausal and postmenopausal symptoms in women experiencing natural or surgical menopause. It is commonly used to treat moderate to severe vasomotor symptoms (hot flashes, flushes), as well as symptoms of vulvovaginal atrophy (dryness, itching, burning). Additionally, it is indicated for the prevention of osteoporosis in women at high risk of fracture who cannot tolerate or have contraindications to non-estrogen therapies. Off-label uses may include hormone replacement in cases of primary ovarian insufficiency or following oophorectomy.
Dosage and direction
Oral tablets: Typically initiated at 0.5 mg to 1 mg daily, taken orally with or without food. Dosage may be adjusted based on symptom response and tolerability, with a maximum recommended dose of 2 mg daily. For women with an intact uterus, a progestin must be added to prevent endometrial hyperplasia.
Vaginal cream: The usual dose is 2 g to 4 g (marked on the applicator) inserted intravaginally once daily for 1–2 weeks, followed by a maintenance dose of 1 g three times per week. Therapy should be discontinued or tapered at 3–6 month intervals to assess the need for continued treatment.
Dosage should be individualized to the lowest effective dose for the shortest duration consistent with treatment goals. Regular reevaluation by a healthcare provider is recommended.
Precautions
- Use the lowest effective dose for the shortest duration to minimize risks
- Regular monitoring of blood pressure, breast health, and pelvic exams is advised
- Annual assessment of bone density may be recommended for osteoporosis prevention
- Discontinue immediately if signs of thrombosis, cardiovascular events, or malignancy appear
- Caution advised in patients with conditions that may be influenced by fluid retention (asthma, epilepsy, migraine, cardiac or renal dysfunction)
- May impair glucose tolerance—monitor blood glucose in diabetic patients
- Not recommended for use beyond 4–5 years without thorough risk-benefit evaluation
Contraindications
- Known or suspected pregnancy
- Undiagnosed abnormal genital bleeding
- Known, suspected, or history of breast cancer
- Known or suspected estrogen-dependent neoplasia
- Active or history of arterial thromboembolic disease (e.g., stroke, myocardial infarction)
- Active or recent venous thromboembolism (e.g., DVT, pulmonary embolism)
- Liver dysfunction or disease
- Protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders
- Hypersensitivity to estradiol or any component of the formulation
Possible side effects
Common:
- Nausea, vomiting, abdominal cramps
- Breast tenderness or enlargement
- Headache, migraine
- Fluid retention, edema
- Spotting or breakthrough bleeding (especially during initial months)
Serious (require immediate medical attention):
- Chest pain, shortness of breath, hemoptysis (possible pulmonary embolism)
- Sudden vision changes, diplopia, retinal vascular lesions
- Severe abdominal pain, jaundice (hepatic impairment)
- New breast lumps, skin changes, or nipple discharge
- Sudden severe headache, vomiting, dizziness (possible cerebrovascular event)
- Signs of allergic reaction: rash, urticaria, angioedema
Drug interaction
- CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin, St. John’s wort): May decrease estradiol levels and efficacy
- CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, grapefruit juice): May increase estradiol levels and side effects
- Anticoagulants (e.g., warfarin): Estrogens may increase or decrease anticoagulant effect; monitor INR closely
- Corticosteroids: Enhanced anti-inflammatory effects; may require dose adjustment
- Thyroid hormone replacement: Estrogens may increase thyroid-binding globulin, necessitating higher thyroxine doses
- Herbal supplements (e.g., black cohosh, dong quai): Additive estrogenic effects may increase risk of adverse events
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Resume the regular dosing schedule. For vaginal cream, apply the missed dose if remembered on the same day; otherwise, skip and continue with the next scheduled application.
Overdose
Nausea, vomiting, breast tenderness, abdominal pain, drowsiness, and withdrawal bleeding may occur. There is no specific antidote. Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion was recent. Medical supervision is advised.
Storage
Store at room temperature (20–25°C or 68–77°F), away from light, moisture, and heat. Keep out of reach of children and pets. Do not freeze. Discard any unused medication after the expiration date. Do not flush or pour down the drain; consult a pharmacist for proper disposal.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual medical conditions, contraindications, and risk factors must be evaluated by a physician. Never disregard professional medical advice or delay seeking it because of something you have read here.
Reviews
“Estrace has been a game-changer for managing my severe hot flashes. Within two weeks, my sleep improved dramatically.” — Maria K., 52
“As a gynecologist, I find Estrace reliable and well-tolerated by most patients, especially when started at a low dose.” — Dr. Elaine Roberts, MD
“The vaginal cream restored comfort and intimacy I thought I’d lost. Minimal side effects compared to other options I tried.” — Susan T., 58
“Effective, but required dose adjustments initially. Regular monitoring is key to balancing benefits and risks.” — Jennifer L., 60